The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase II study of radiation therapy (RT), paclitaxel poliglumex (PPX), and cetuximab (C) in locally advanced head and neck cancer (LA-HNC).
Seung Shin Hahn
No relevant relationships to disclose
Jeffrey Bogart
No relevant relationships to disclose
Chung Taik Chung
No relevant relationships to disclose
Jack Hsu
No relevant relationships to disclose
Robert Kellman
No relevant relationships to disclose
Michael Andrew Lacombe
No relevant relationships to disclose
Jung-AH Kim
No relevant relationships to disclose
Stephen L. Graziano
No relevant relationships to disclose
Dena Martin
No relevant relationships to disclose
Ajeet Gajra
No relevant relationships to disclose